Archived article
Please note that tax, investment, pension and ISA rules can change and the information and any views contained in this article may now be inaccurate.
ConvaTec Group PLC - Reading, England-based medical products and technologies company - Completes $125 million acquisition of Triad Life Sciences Inc, a Memphis, Tennessee-based company focused on developing biological products for surgical wounds. Triad's portfolio and product pipeline will now be absorbed into ConvaTec's Advanced Wound Care business, and become known as ConvaTec Advanced Tissue Technology.
In the two years post-completion, there are two earnout payments conditional on Triad's performance, up to a maximum earnout of $275 million.
Current stock price: 178.55 pence, up 1.3% on Monday
12-month change: down 7.0%
Copyright 2022 Alliance News Limited. All Rights Reserved.